Guidelines on muscle relaxants and reversal in anaesthesia.
Fiche publication
Date publication
janvier 2020
Journal
Anaesthesia, critical care & pain medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Dr RAFT Julien
Tous les auteurs :
Plaud B, Baillard C, Bourgain JL, Bouroche G, Desplanque L, Devys JM, Fletcher D, Fuchs-Buder T, Lebuffe G, Meistelman C, Motamed C, Raft J, Servin F, Sirieix D, Slim K, Velly L, Verdonk F, Debaene B
Lien Pubmed
Résumé
To provide an update to the 1999 French guidelines on "Muscle relaxants and reversal in anaesthesia", a consensus committee of sixteen experts was convened. A formal policy of declaration and monitoring of conflicts of interest (COI) was developed at the outset of the process and enforced throughout. The entire guidelines process was conducted independently of any industrial funding (i.e. pharmaceutical, medical devices). The authors were required to follow the rules of the Grading of Recommendations Assessment, Development and Evaluation (GRADE®) system to assess the quality of the evidence on which the recommendations were based. The potential drawbacks of making strong recommendations based on low-quality evidence were stressed. Few of the recommendations remained ungraded.
Mots clés
Monitoring, Muscle relaxants, Neuromuscular, Reversal, Update of experts’ guidelines
Référence
Anaesth Crit Care Pain Med. 2020 Jan 8;: